ECM
Endurant Capital Management Portfolio holdings
AUM
$17.4M
This Quarter Return
-2.06%
1 Year Return
+4.95%
3 Year Return
+16.8%
5 Year Return
+58.39%
10 Year Return
–
AUM
$268M
AUM Growth
+$268M
(-18%)
Cap. Flow
-$51.2M
Cap. Flow
% of AUM
-19.11%
Top 10 Holdings %
Top 10 Hldgs %
44.52%
Holding
92
New
17
Increased
19
Reduced
32
Closed
23
Top Buys
| 1 |
Universal Health Services
UHS
|
$9.88M |
| 2 |
Abbott
ABT
|
$7.99M |
| 3 |
Johnson & Johnson
JNJ
|
$6.83M |
| 4 |
Becton Dickinson
BDX
|
$6.28M |
| 5 |
Elevance Health
ELV
|
$4.74M |
Top Sells
| 1 |
Danaher
DHR
|
$9.04M |
| 2 |
McKesson
MCK
|
$8.53M |
| 3 |
TVTY
Tivity Health, Inc. Common Stock
TVTY
|
$7.85M |
| 4 |
VanEck Biotech ETF
BBH
|
$6.22M |
| 5 |
Sabra Healthcare REIT
SBRA
|
$6.16M |
Sector Composition
| 1 | Healthcare | 93.35% |
| 2 | Real Estate | 1.88% |
| 3 | Financials | 1.53% |
| 4 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AGN
1
DELISTED
Allergan plc
AGN
| $17.2M | 6.44% | 102,391 +25,900 | +34% | +$4.36M |
|
|
2
Abbott
ABT
$231B
| $16.6M | 6.19% | 276,732 +133,349 | +93% | +$7.99M |
|
|
3
Johnson & Johnson
JNJ
$427B
| $14.6M | 5.46% | 114,111 +53,311 | +88% | +$6.83M |
|
4
Medtronic
MDT
$119B
| $10.8M | 4.05% | 135,115 +18,800 | +16% | +$1.51M |
|
|
5
Becton Dickinson
BDX
$55.3B
| $10.6M | 3.97% | 49,030 +28,960 | +144% | +$6.28M |
|
6
Boston Scientific
BSX
$156B
| $10.6M | 3.96% | 387,698 +45,100 | +13% | +$1.23M |
|
|
7
Universal Health Services
UHS
$11.6B
| $9.88M | 3.69% | +83,400 | New | +$9.88M |
|
8
UnitedHealth
UNH
$281B
| $9.72M | 3.63% | 45,408 +6,752 | +17% | +$1.44M |
|
|
9
Elevance Health
ELV
$71.8B
| $9.69M | 3.62% | 44,105 +21,594 | +96% | +$4.74M |
|
10
Merck
MRK
$210B
| $9.41M | 3.51% | 172,700 +66,600 | +63% | +$3.63M |
|
11
DaVita
DVA
$9.85B
| $9.32M | 3.48% | 141,336 -73,377 | -34% | -$4.84M |
|
|
SHPG
12
DELISTED
Shire pic
SHPG
| $8.07M | 3.01% | 53,996 +21,300 | +65% | +$3.18M |
|
|
WBA
13
DELISTED
Walgreens Boots Alliance
WBA
| $7.87M | 2.94% | 120,223 -60,000 | -33% | -$3.93M |
|
|
SYNH
14
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $6.83M | 2.55% | 192,400 +79,500 | +70% | +$2.82M |
|
15
CVS Health
CVS
$92.8B
| $6.48M | 2.42% | 104,111 +50,811 | +95% | +$3.16M |
|
16
Viatris
VTRS
$12.3B
| $6.44M | 2.41% | 156,487 +37,600 | +32% | +$1.55M |
|
17
Hologic
HOLX
$14.9B
| $6.39M | 2.39% | 170,944 -51,900 | -23% | -$1.94M |
|
|
18
Sabra Healthcare REIT
SBRA
$4.58B
| $5.03M | 1.88% | 285,219 -349,200 | -55% | -$6.16M |
|
19
Thermo Fisher Scientific
TMO
$186B
| $4.92M | 1.84% | 23,808 -19,800 | -45% | -$4.09M |
|
20
Labcorp
LH
$23.1B
| $4.78M | 1.79% | 29,575 +9,000 | +44% | +$1.46M |
|
21
HCA Healthcare
HCA
$94.5B
| $4.35M | 1.62% | +44,800 | New | +$4.35M |
|
22
Pediatrix Medical
MD
$1.5B
| $4.13M | 1.54% | 74,217 -107,500 | -59% | -$5.98M |
|
|
AET
23
DELISTED
Aetna Inc
AET
| $4.11M | 1.53% | 24,312 -15,115 | -38% | -$2.55M |
|
|
ESRX
24
DELISTED
Express Scripts Holding Company
ESRX
| $3.79M | 1.41% | 54,790 -19,900 | -27% | -$1.37M |
|
25
Gilead Sciences
GILD
$140B
| $3.56M | 1.33% | +47,200 | New | +$3.56M |
|